We Venture Capital logo

We Venture Capital

Description

Early stage diagnostics investor

Investor Profile

We Venture Capital has backed more than 6 startups, with 4 new investments in the last 12 months alone. The firm has led 3 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed, Series C rounds (top funding stages).
  • Majority of deals are located in United Kingdom, Sweden, Canada.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (50%)
  • Seed (33%)
  • Series C (17%)

Country Focus

  • United Kingdom (50%)
  • Sweden (17%)
  • Canada (17%)
  • Spain (17%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
  • Health Diagnostics
  • Precision Medicine
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does We Venture Capital frequently co-invest with?

Nina Capital
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 1
Tenmile
Oceania, Western Australia, Australia, Perth
Co-Investments: 1
E
Europe, Veneto, Italy, San Giovanni Lupatoto
Co-Investments: 1
Co-Investments: 1
Sciety
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
APEX Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 1
University of Cambridge Enterprise
Europe, Cambridgeshire, United Kingdom, Cambridge
Co-Investments: 1
15th Rock
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
LongeVC
Europe, Ticino, Switzerland, Lugano
Co-Investments: 1

What are some of recent deals done by We Venture Capital?

Respiree

Singapore, Central Region, Singapore

Respiree is a healthcare service.

Health CareHome Health Care
Series AJul 23, 2025
Amount Raised: $11,600,000
Portal Biotech

London, England, United Kingdom

Portal Biotech is a biotechnology company specializing in advanced proteomics and metabolomics through single-molecule detection.

Biotechnology
Series AJun 30, 2025
Amount Raised: $37,073,704
DeepUll

Barcelona, Catalonia, Spain

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

BiotechnologyLife Science
Series CApr 29, 2025
Amount Raised: $57,074,303
OxCan

Oxford, Oxfordshire, United Kingdom

OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.

BiotechnologyHealth CareHealth Diagnostics
Series AJan 9, 2025
Amount Raised: $11,000,000
Proton Intelligence

Vancouver, British Columbia, Canada

Proton Intelligence provides biomarker monitoring to manage chronic disease and save lives.

Health CareHealth DiagnosticsMedicalMedical Device
SeedDec 24, 2024
Amount Raised: $6,950,000
Capitainer

Stockholm, Stockholms Lan, Sweden

Capitainer enables patients to collect their own volume-defined dried blood spot at home.

Health Care
Series AFeb 15, 2024
Amount Raised: $1,435,165
Zetta Genomics

Cambridge, Cambridgeshire, United Kingdom

Zetta Genomics manages large-scale genomic data for precision medicine.

BiotechnologyLife ScienceMedicalPrecision Medicine
SeedFeb 8, 2024
Amount Raised: $2,271,758